Literature DB >> 31311800

Early Detection of Peripheral Blood Cell Signature in Children Developing β-Cell Autoimmunity at a Young Age.

Henna Kallionpää1, Juhi Somani2, Soile Tuomela1, Ubaid Ullah1, Rafael de Albuquerque1, Tapio Lönnberg1, Elina Komsi1, Heli Siljander3,4, Jarno Honkanen3,4, Taina Härkönen3,4, Aleksandr Peet5,6, Vallo Tillmann5,6, Vikash Chandra3,7, Mahesh Kumar Anagandula8, Gun Frisk8, Timo Otonkoski3,7, Omid Rasool1, Riikka Lund1, Harri Lähdesmäki2, Mikael Knip3,4,9,10, Riitta Lahesmaa11.   

Abstract

The appearance of type 1 diabetes (T1D)-associated autoantibodies is the first and only measurable parameter to predict progression toward T1D in genetically susceptible individuals. However, autoantibodies indicate an active autoimmune reaction, wherein the immune tolerance is already broken. Therefore, there is a clear and urgent need for new biomarkers that predict the onset of the autoimmune reaction preceding autoantibody positivity or reflect progressive β-cell destruction. Here we report the mRNA sequencing-based analysis of 306 samples including fractionated samples of CD4+ and CD8+ T cells as well as CD4-CD8- cell fractions and unfractionated peripheral blood mononuclear cell samples longitudinally collected from seven children who developed β-cell autoimmunity (case subjects) at a young age and matched control subjects. We identified transcripts, including interleukin 32 (IL32), that were upregulated before T1D-associated autoantibodies appeared. Single-cell RNA sequencing studies revealed that high IL32 in case samples was contributed mainly by activated T cells and NK cells. Further, we showed that IL32 expression can be induced by a virus and cytokines in pancreatic islets and β-cells, respectively. The results provide a basis for early detection of aberrations in the immune system function before T1D and suggest a potential role for IL32 in the pathogenesis of T1D.
© 2019 by the American Diabetes Association.

Entities:  

Year:  2019        PMID: 31311800     DOI: 10.2337/db19-0287

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  The Application of Single-Cell RNA Sequencing in Studies of Autoimmune Diseases: a Comprehensive Review.

Authors:  Mingming Zhao; Jiao Jiang; Ming Zhao; Christopher Chang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-25       Impact factor: 8.667

2.  Cytotoxicity-Related Gene Expression and Chromatin Accessibility Define a Subset of CD4+ T Cells That Mark Progression to Type 1 Diabetes.

Authors:  Naiara G Bediaga; Alexandra L Garnham; Gaetano Naselli; Esther Bandala-Sanchez; Natalie L Stone; Joanna Cobb; Jessica E Harbison; John M Wentworth; Annette-G Ziegler; Jennifer J Couper; Gordon K Smyth; Leonard C Harrison
Journal:  Diabetes       Date:  2022-03-01       Impact factor: 9.461

3.  HLA Allele-Specific Quantitative Profiling of Type 1 Diabetic B Lymphocyte Immunopeptidome.

Authors:  Putty-Reddy Sudhir; Tai-Du Lin; Qibin Zhang
Journal:  J Proteome Res       Date:  2021-12-21       Impact factor: 5.370

Review 4.  Type 1 Diabetes: Interferons and the Aftermath of Pancreatic Beta-Cell Enteroviral Infection.

Authors:  Pouria Akhbari; Sarah J Richardson; Noel G Morgan
Journal:  Microorganisms       Date:  2020-09-15

Review 5.  The Role of Natural Killer Cells in Autoimmune Diseases.

Authors:  Umut Can Kucuksezer; Esin Aktas Cetin; Fehim Esen; Ilhan Tahrali; Nilgun Akdeniz; Metin Yusuf Gelmez; Gunnur Deniz
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 6.  Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?

Authors:  Elena Gianchecchi; Domenico V Delfino; Alessandra Fierabracci
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

7.  lgpr: An interpretable nonparametric method for inferring covariate effects from longitudinal Data.

Authors:  Juho Timonen; Henrik Mannerström; Aki Vehtari; Harri Lähdesmäki
Journal:  Bioinformatics       Date:  2021-01-20       Impact factor: 6.937

8.  Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes.

Authors:  Guanlan Xu; Tiffany D Grimes; Truman B Grayson; Junqin Chen; Lance A Thielen; Hubert M Tse; Peng Li; Matt Kanke; Tai-Tu Lin; Athena A Schepmoes; Adam C Swensen; Vladislav A Petyuk; Fernando Ovalle; Praveen Sethupathy; Wei-Jun Qian; Anath Shalev
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 14.919

Review 9.  Insights From Single Cell RNA Sequencing Into the Immunology of Type 1 Diabetes- Cell Phenotypes and Antigen Specificity.

Authors:  Stephanie J Hanna; Danijela Tatovic; Terri C Thayer; Colin M Dayan
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

10.  Peripheral autoreactive CD8 T-cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes.

Authors:  Johnna D Wesley; Susanne Pfeiffer; Darius Schneider; David Friedrich; Nikole Perdue; Birgit Sehested-Hansen; William Hagopian; Matthias G von Herrath
Journal:  Clin Transl Immunology       Date:  2021-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.